Study of Home-Embedded Palliative Care for Hemodialysis- (and Peritoneal-) Dependent End-Stage Renal Disease
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 315 people enrolled
- Started
- 14 Dec 2023
- Ended
- 11 Nov 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Nudge for PHPC NP Referral
- Record updated
- 27 January 2025
- Why it stopped
- Effectiveness of home palliative care services could not be determined due to lower-than-expected referrals and consults in the intervention arm
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Be an adult (18 years of age or older) hospitalized at a Penn study hospital
- AND digital signature of ESRD (N18.6) within the last 12 months
- AND resides in the five-county area surrounding Philadelphia which is served by Penn Palliative Care Nurse Practitioner program
- AND have one or more of the following markers of potentially unmet needs: (i) existing home care eligibility or referral for home care (but not already receiving PC); (ii) non-ambulatory status determined via nursing assessment; (iii) severe protein-calorie malnutrition; (iv) 2 or more hospitalizations within the prior year
Who cannot take part
- Patients with functional kidney transplants
- Patients discharged to skilled nursing facilities and LTC facilities
Where in United States
- University of PennsylvaniaPhiladelphia, United States
About the trial
What the trial wants to find out
Home palliative care needs are often under-recognized in patients with End-Stage Renal Disease (ESRD). This pilot study is designed to evaluate the effectiveness of referrals to home palliative care services in improving patient outcomes compared with usual care among patients with ESRD admitted to a Penn hospital. Evaluating the effectiveness of home palliative care services is critical to determine whether increasing access to these services would improve patient-centered outcomes for these high-need patients
The 2 groups in the trial
- InterventionTreatment being tested
The inpatient care team, including the attending/ordering and covering providers, for participants in this group will receive a message from the research team identifying their patient as appropriate for home palliative care and will be asked to refer their patient for these services.
Treatment: Nudge for PHPC NP Referral
- Usual CareNo study treatment, for comparison
Participants in this group will receive usual care upon discharge from the hospital. Their clinical team will not be notified that they are appropriate for home palliative care services, but they may still be referred for those services if their clinicians feel their patient will benefit.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of Home-Embedded Palliative Care for Hemodialysis- (and Peritoneal-) Dependent End-Stage Renal Disease (SHEPHERD 2.0)
- Record updated
- 27 January 2025